Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by sleepydog1on Mar 29, 2019 6:13am
158 Views
Post# 29552450

The future is now for GEN

The future is now for GEN... I believe closing this deal through Telepath will lead to the health insurance companies coming on board .... then after that network is put in place nationwide in the States with Telepath and the health insurance companies they begin to roll out Aristotle which in Tripps recent interview through the Richmond club stated " would take GEN from $30 million + to $2 billion revenue in the next 2 years " .... this is why it is so crucial to raise the money he has and will in the first half of this year to make sure in house capital or lack there of doesn't hold back these impending initiatives.........And also I'd like to add if we do get to $2 billion in revenue in 2 years the norm would be trading at 5 - 10 times revenue for a marketcap ... well with 200 million shares out or there abouts I think everyone here can do that easy back of the envelope math .... we are not gonna just sit and wait till then to go from .20 to $10 / share .... the market once it sees what is coming always is 6 months ahead of actual reality .... therefore with yestardays news with Telepath that alone will give us our $30 mill revenue easy which at 5 rev should put us up towards a $1 .... market will take us there on this news just they will shake out all the flippers and weak hands best they can early on .... that is what you have seen over the last month .... once we get above .20 we will start to have .05 to .10 jumps a day in share appreciation and it won't be as hard as it seems right now .
Bullboard Posts